Value Bridge — UNIVERSITY OF MIAMI HOSP & CLINICS
Current $22M → Target $75M (+$52.2M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$22.5M
Current EBITDA
$74.7M
Target EBITDA
+$52.2M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$11.8M
Payer Mix Optimization
$28.4M
Cost to Collect Reduction
$9.5M
Clean Claim Improvement
$7.1M
Volume & Rate Growth
$47.3M
What This Means
The 7-lever model projects a 233% EBITDA uplift from $22M to $75M. The highest-impact lever is Volume & Rate Growth at $18.9M probability-weighted.
IC talking point: "We see $52M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $575M in equity value creation."